Abstract
The striatum plays a crucial role in providing input to the basal ganglia circuit and is implicated in the pathological process of Parkinson’s disease (PD). Disruption of the dynamic equilibrium in the basal ganglia loop can be attributed to the abnormal functioning of the medium spiny neurons (MSNs) within the striatum, potentially acting as a trigger for PD. Exercise has been shown to mitigate striatal neuronal dysfunction through neuroprotective and neurorestorative effects and to improve behavioral deficits in PD model mice. In addition, this effect is offset by the activation of MSNs expressing dopamine D2 receptors (D2-MSNs). In the current study, we investigated the underlying neurobiological mechanisms of this effect. Our findings indicated that exercise reduces the power spectral density of the beta-band in the striatum and decreases the overall firing frequency of MSNs, particularly in the case of striatal D2-MSNs. These observations were consistent with the results of molecular biology experiments, which revealed that aerobic training specifically enhanced the expression of striatal dopamine D2 receptors (D2R). Taken together, our results suggest that aerobic training aimed at upregulating striatal D2R expression to inhibit the functional activity of D2-MSNs represents a potential therapeutic strategy for the amelioration of motor dysfunction in PD.
Keywords: Parkinson's disease, Motor dysfunctions, Aerobic exercise, Striatum, D2-MSNs
Subject terms: Neuroscience, Diseases of the nervous system, Motor control
Introduction
Aging of the global population is a prominent demographic trend that has been accompanied by a rapid increase in the prevalence of neurodegenerative conditions such as Alzheimer's disease (AD), Parkinson’s disease (PD), and mild cognitive impairment1,2. Among these, PD is one of the common prevalent neurodegenerative conditions, with a significantly higher incidence among individuals aged > 60 years3. The underlying pathology of PD involves the progressive degeneration of dopamine (DA)-producing neurons, primarily in the substantia nigra pars compacta (SNpc). This neuronal loss leads to a substantial reduction in striatal DA levels, resulting in widespread motor and nonmotor dysfunction4.
The basal ganglia, a collection of subcortical nuclei, coordinates autonomous motor behaviors in the human body. In PD, the lack of DA in the striatum disrupts the internal motor control loop within the basal ganglia, thereby contributing to significant motor impairment5. The conventional model posits that the basal ganglia comprise two parallel neural circuits (direct and indirect pathways) originating from distinct subtypes of medium spiny neurons (MSNs) in the striatum6. In general, these two pathways exert opposing effects on the regulation of autonomous movement. The direct pathway acts as a "go" signal to facilitate motor behavior, while the indirect pathway serves as a "no-go" signal to inhibit motor behavior7. These DA-driven pathways can be activated concurrently during specific motor behaviors, suggesting a collaborative role in regulating autonomous movement8,9. Both Spike and local field potentials (LFP) are fundamental components of brain activity. LFP oscillations are the sum of local membrane currents and synaptic activity in the brain, reflecting afferent activity between neurons. Abnormal LFP patterns are considered to be key biomarkers of brain dysfunction. Changes in synchronised activity between multiple nuclei on the PD basal ganglia loop, particularly in the beta band of LFP10. Furthermore, multiple studies have revealed abnormal DA receptor function in striatal MSNs among human patients and animal models of PD11–14, along with structural and functional alterations in MSNs such as dendritic spine loss and changes in the synaptic ultrastructure15. Consequently, researchers have speculated that DA-mediated changes in synaptic plasticity within MSNs of the striatum may underlie PD-related motor dysfunction.
Considerable evidence supports the notion that aerobic exercise can significantly ameliorate motor and behavioral impairments in patients with PD. In the realm of animal research, the enforced utilization of the injury-contralateral forelimb in PD model mice has been shown to facilitate the recuperation of motor dysfunction in the affected limb. This approach also mitigates damage to dopaminergic terminals. These beneficial effects are closely linked to exercise-induced plasticity of striatal MSNs, encompassing both morphological and functional aspects. For instance, physical activity facilitates morphological and structural remodeling of striatal MSNs in PD model rats, achieved through the upregulation of synaptic junction protein expression16. Concurrently, prior research has demonstrated that physical activity reduces the frequency and amplitude of spontaneous excitatory postsynaptic currents (sEPSCs) and elevates the paired-pulse ratio of D2-MSNs, without altering the fundamental electrophysiological properties of MSNs17. Aerobic exercise has also been shown to modulate neuronal excitability by enhancing the expression of D2R in striatal MSNs, thereby mitigating motor and behavioral dysfunction in animal models of PD17. Nonetheless, the precise roles of the different MSN subtypes in the striatum remain unclear. In the present study, we aimed to investigate the involvement of striatal DA receptors and the associated plasticity of MSNs in regulating motor deficits observed in PD mice during aerobic exercise. In exploring the neurobiological mechanisms mediated by different MSN subtypes, we sought to provide novel theoretical insights into the mechanisms underlying the attenuation of PD-induced deficits in motor function through aerobic exercise.
Materials and methods
Ethics information
All experimental methods for this study were carried out in accordance with relevant guidelines and regulations and approved by the Ethics Committee of Hebei Normal University (2020LSC41). All experimental methods were reported in accordance with the ARRIVE guidelines. All efforts were made to minimize the number of animals used and their suffering.
Animals
Considering the reported male predominance in PD, and in our endeavor to minimize potential experimental confounds that might arise from the variable estrous cycles in female mice, our study design was strategically aligned with these considerations. A total of 54 C57BL/6 male mice (8 weeks old, 20 ± 1 g) were purchased from Changsheng Laboratory Animal Platform (Changsheng, Benxi, China). The C57BL/6 mice were randomly divided into two groups: 6-Hydroxydopamine (6-OHDA) group (n = 32) and saline group (n = 22). The saline group mice were divided into Control group (C, n = 11) and Control + Exercise group (CE, n = 11). A total of 22 successful mice in the 6-OHDA group were randomly divided into PD group (PD, n = 11) and PD + Exercise group (PE, n = 11). The mice had free access to food and water and were housed under a 12/12-h light/dark cycle (natural light) in an animal room with a temperature of approximately 22 °C and relative humidity of 50–60%.
Adeno-associated virus (AAV) injection
Mice were anesthetized using 3% isoflurane gas, which was subsequently reduced and maintained at 1%. Deep anesthesia was achieved, and the animals were positioned in a brain stereotaxic apparatus for the surgical procedure. An incision was made in the skin, and the levels of the anterior and posterior fontanelles were adjusted to facilitate localization of the right striatum (AP: + 0.9 mm, ML: − 1.8 mm; DV: − 2.8 mm) based on the mouse brain localization atlas (see Fig. 1). A microinjection pump was utilized to administer a 1 μL mixture of viruses (BrainVTA, Wuhan, China) containing mCherry (2.81E + 12 vg/mL) and D2-Cre (2.37E + 12 vg/mL), with each virus comprising 0.5 μL, at a controlled rate of 100 nL/min. Upon completion of injection, the needle was carefully and uniformly withdrawn.
Establishment and validation of the PD model
6-OHDA surgery was performed 3 weeks after virus transfection. The mice were deeply anesthetized to align the bregma and lambda of the skull, and posterior holes were drilled at the specified coordinates for the localized striatum (AP: + 0.5 mm, ML: − 1.8 mm; DV: − 3 mm, − 2 mm). A solution of 6-OHDA (Sigma-Aldrich, Saint Louis, USA) with ascorbic acid saline (2 μg/μL) was then injected into the right striatum at a controlled rate of 500 nL/min, at a total volume of 4 μL. In the shamoperated group, an equivalent volume of 0.02% ascorbic acid saline was administered18.
On the 7th day post 6-OHDA injection, the PD model mice were assessed using an apomorphine (APO)-induced rotation test. Following intraperitoneal injection of an APO solution (0.5 μg/g), rotations exceeding 120 within a 30-min duration were considered indicative of successful PD model establishment. Mice that passed the apomorphine-induced rotation test were randomly divided into two groups. Mice that failed the rotation test, were excluded from further experiments. The reliability of the PD model was further confirmed via immunohistochemical analysis of tyrosine hydroxylase (TH) expression in the nigrostriatal system.
Implantation of optical fibers and optoelectrodes
To facilitate data collection during behavioral experiments, an optical fiber insertion needle with a numerical aperture of 0.37 μm and a diameter of 200 μm was utilized. The optical fiber insertion needle was secured on the optical fiber holder, and the position of the striatum (AP: + 0.9 mm, ML: − 1.8 mm) was accurately identified. The needle was then uniformly to a depth of 100 μm below the site of AAV injection.
To facilitate data collection during electrophysiological experiments, a 16-channel optoelectrode was implanted. An opening measuring 1 × 1 mm was drilled above the striatum. The electrode was gradually advanced from this opening at a rate of 0.1 mm/min to approach the dorsal striatum. When this depth was reached and two or more channels of neurons consistently responded to light stimulation, advancement of the optoelectrode was halted.
Aerobic exercise intervention
According to previous research, aerobic exercise intervention will begin 7 days after 6-OHDA surgery18. CE and PE mice underwent a 4-week aerobic exercise intervention using a treadmill designed for small animals, in accordance with the following protocol: treadmill slope of 0°, training speed of 18 m/min, and session duration of 50 min/day. This 50 min duration included a 5 min warm-up and a 5 min cool-down period, during which the running speed was maintained at 10 m/min. The training regimen spanned 4 weeks, with training sessions conducted continuously for 5 days per week. The target exercise intensity was approximately 70–76% of VO2max19. Before initiating aerobic exercise, exercise intensity was assessed using a metabolic system designed for small animals to ensure compliance with the prescribed standards for aerobic exercise. Maximum oxygen uptake was assessed with the Columbia Small Animal Metabolic System. The testing protocol proceeded as follows: initially, a three-day period of acclimation involving closed gas-exchange treadmill training was conducted before the official assessments. Subsequently, locomotor performance and maximal oxygen uptake were evaluated through a graded incremental methodology applied to treadmill speed for small animals. In the formal assessment, each mouse was positioned on a closed running platform with a 0° incline, utilizing oxygen and carbon dioxide measurements to detect the exhaled gases. Upon stabilization of the animal's oxygen consumption, the running platform initiated at 5 m/min, with speed increments of 4 m/min every 3 min, until the mouse could no longer sustain a specified pace. This threshold was identified as the maximum oxygen uptake and its corresponding running speed. Utilizing the running speed and associated maximal oxygen uptake, the running speed corresponding to 70–76% of VO2max was established for each mouse group.
Behavioral testing
Pole test
To assess motor coordination and impairments, mice were subjected to a pole-climbing test20. A climbing pole with a length of 50 cm and a diameter of 1 cm was used, featuring a wooden ball positioned at the top. The mouse was positioned on the ball with its head facing downwards, and the time taken for it to descend from the top to the bottom of the pole was recorded. Each mouse underwent five tests, they were before the exercise intervention and after the weekly exercise intervention. Following completion of the exercise intervention, an optogenetic experiment was conducted in both open and closed optogenetic stimulation states. For the optogenetic stimulation stage, the light was on throughout the entire duration of the trial. Blue light stimulation with a wavelength of 473 nm, power ranging from to 1–5 mW, frequency of 10 Hz, and a pulse width of 20 ms was employed.
Cylinder test
The cylinder test is primarily used to assess forelimb asymmetry in hemiparkinsonian animals. Generally, when placed in a cylinder, a mouse explores and adapts to its surroundings by moving and using its forelimbs to touch the walls. In the hemiparkinsonian model, impaired control of left forelimb movement results in an asymmetry in bilateral limb usage. During the experiment, the mice were placed in a cylinder measuring 15 cm in height and 12 cm in diameter, and contact of the forelimbs with the cylinder wall was recorded for 3 min. Left forelimb usage was calculated as follows: (number of left paw contacts + number of bilateral paw contacts/2)/(number of left paw contacts + number of bilateral paw contacts + number of right paw contacts) × 100%21. The optogenetic stimulation mode used for the cylinder test matched that used for the previous behavioral test, and the intensity, frequency, and wavelength were in accordance with the plan outlined by Yoon22,23.
In vivo electrophysiological recording
Following completion of the exercise intervention, a 128-channel neural electrophysiological recording system was used to collect, amplify, and filter electrical signals in the striatum. To activate the D2-MSNs, an intelligent dual-light source optogenetic system utilizing 473 nm blue light was employed (Fig. 2). The recorded signals were extracted through a headstage, and the extracellular action potentials of striatal neurons (Spikes, sampling rate of 30 kHz) and LFP (bandpass filter set to 0.5–250 Hz, sampling rate of 2 kHz) were recorded separately. Electrical signals were collected during baseline and optogenetic stimulation states for each mouse group. As delineated by Wei et al. (2022), an effective signal-to-noise ratio exceeding 3:1, coupled with an automated waveform detection function, establishes thresholds that segregate individual channel waveforms into distinct clusters. This segregation is accomplished through the utilization of Principal Component Analysis (PCA). Subsequently, the analysis involves examining whether the histogram of peak-to-peak intervals adheres to a Poisson distribution (see Fig. 6C). Additionally, this process entails the extraction of both the peak-to-valley and peak-to-peak durations from the characteristic curves of each neuronal waveform (refer to Fig. 6D–F). Refer to Soares-Cunha et al. to distinguish D1-MSNs from D2-MSNs24. The parameters for optogenetic stimulation mode were 473 nm of blue light with a power range of 1–5 mW, frequency of 10 Hz, and pulse width of 20 ms.
Molecular experiments
Western blotting
Mice were deeply anaesthetised using isoflurane and then euthanised by decapitation. Mice brains were immediately removed by dissection. The striatum tissues were harvested and protein samples were prepared by tissue lysis. For Western blotting analysis, 20 μg of the striatum protein sample was loaded onto an SDS-PAGE gel and separated using constant voltage mode electrophoresis. Subsequently, the proteins in the gel were transferred onto preactivated polyvinylidene fluoride (PVDF) membranes. To prevent nonspecific binding, the membranes were blocked with 5% skim milk in TBST for 2 h. Following the blocking step, the membranes were incubated overnight at 4 °C with primary antibodies targeting the specific protein of interest (TH, 1:1000, HUABIO; D1R/D2R, 1:1000, Affinity) as well as β-actin and GAPDH (1:10,000, ABclonal) as a loading control. After incubation with the primary antibodies, the PVDF membranes were washed with TBST and incubated with a secondary antibody (HRP goat anti-rabbit IgG, 1:10,000, ABclonal) that specifically binds to the primary antibody at room temperature for 1 h on a shaker. The chemiluminescent signal was visualized using the FusionFX automatic imaging system.
Immunohistochemistry
The mouse brains were swiftly removed and fixed in 4% paraformaldehyde for 24 h. After fixation, the brain tissue was dehydrated using a sucrose gradient solution (20%, 30%, and 30% in PB) and embedded in the OCT compound. The embedded tissue was frozen on a cryostat, and coronal sections (thickness: 15 μm) were obtained once the target brain region had been reached. To retrieve antigens, the sections were initially treated with an antigen retrieval buffer (pH = 6.0). Subsequently, brain slices were incubated with an endogenous peroxidase inhibitor (PV-9001, ZSGB-BIO) at room temperature for 20 min. Primary antibody (TH, 1:200, HUABIO) was then added to the sections and incubated for 1 h at 37 °C. A reaction enhancer was applied to cover the tissue, which was incubated at room temperature for 20 min. Next, HRP-conjugated goat anti-rabbit IgG was added, and the sample was incubated for an additional 20 min, following which DAB staining was performed. In addition Brain sections were washed with 0.01 M PBS between the above steps. The brain sections were dehydrated using different concentrations of ethanol and xylene and were finally sealed with a neutral resin adhesive to preserve the tissue.
Immunofluorescence
Brain slices were thawed from − 80 °C and allowed to reach room temperature. They were then washed three times for 5 min each using a 0.01 M PBS solution. Following washing, brain slices were placed in a buffered repair solution for antigen retrieval. The buffered repair solution was boiled in a microwave oven for 6 min in high mode and then for 10 min in low mode. Subsequently, the brain slices were removed and allowed to cool to room temperature. They were washed three times for 5 min each with PBS. For incubation with the primary antibody solution, the sections were carefully treated with a diluted solution containing BSA and the primary antibody (D2R, 1:500, Affinity) at 4 °C overnight. The next day, the slices were brought back to room temperature and incubated with the secondary antibody (1:500, Immunoway) for 50 min at 37 °C. Subsequently, the cells were washed three times with PBS for 5 min each. Finally, sections were incubated with DAPI (Cell Signaling Technology, Boston, USA) and sealed with an antifluorescence attenuator. Panoramic images were obtained using a panoramic electronic display microscope. Fluorescent colors represent DAPI (blue) and D2R (red).
Statistical analysis
The data were analyzed using SPSS 25.0 and GraphPad Prism 8 software. Repeated-measures analyses of variance (ANOVA) were used to compare behavioral indices before and after aerobic training in different groups of mice. The effects of the three main factors (aerobic training, 6-OHDA, and training time) on motor behavior were evaluated in each group of mice. When interactions between any of the three main factors was statistically significant (P < 0.05), further analysis was conducted to examine the main effects at different levels of aerobic training and 6-OHDA. Conversely, when there were no significant interactions between factors (P > 0.05), the main effects were compared. When an interaction effect was still present between two factors (P < 0.05), a simple effect analysis was performed, and a two-way analysis of variance was employed to compare variables after aerobic training. The main effects of aerobic training and 6-OHDA were assessed, and if the interaction effect was not significant (P > 0.05), the main effects were compared. However, if the interaction effect was significant (P < 0.05), a simple effect analysis was performed, and the paired-samples t-test was used to compare behavioral indicators within each group before and after light stimulation. Multiple comparisons were conducted using the least-significant-difference (LSD) test, and the level of statistical significance was set to P < 0.05.
Results
Evaluation of PD model mice
As shown in Fig. 3A, 22 mice exhibited rotational cycles exceeding 120 turns/30 min. Hence, the final success rate for establishing a lateral PD model in this study was 68.75%. After randomized grouping, there was no statistically significant difference in the number of rotational turns between PD and PE mice (Supplementary Fig. S1). Figure 3D shows the western blotting results for TH protein expression in the striatum in each mouse group. Striatal TH loss proportion were significantly higher in the PD group than in the control group (1.00 ± 0.01 vs 0.32 ± 0.20, P < 0.01, F = 53.322). PE mice exhibited significantly lower loss proportion of striatal TH than the PD group (0.32 ± 0.20 vs 0.61 ± 0.16, P < 0.05, F = 10.032). Furthermore, TH protein expression in the striatum was significantly lower in PE mice than in CE mice (0.61 ± 0.16 vs 1.08 ± 0.21, P < 0.01, F = 28.168).
As shown in Fig. 3, integrated optical density (IOD) values for TH-positive nerve fibers and numbers of TH-positive neurons in the SNpc were significantly lower in the PD group than in the control group (0.99 ± 0.16 vs 0.34 ± 0.43, P < 0.01, F = 73.015; 1.04 ± 0.22 vs 0.19 ± 0.07, P < 0.001, F = 65.333). In contrast, both values were significantly higher in the PE group than in the PD group (IOD: 0.34 ± 0.43 vs 0.57 ± 0.82, F = 7.367; cell number: 0.19 ± 0.07 vs 0.50 ± 0.16, P < 0.05, F = 8.061).
Evaluation of optogenetic model
To achieve targeted expression of red fluorescence in transfected striatal neurons, the rAAV-EF1α-DIO-hChR2(H134R)-mCherry-WRPE-hGH polyA virus was administered. This virus enables visualization of mCherry red fluorescence. As depicted in Fig. 5A, significant red fluorescence was detected in the right striatum of virus-injected mice, whereas no fluorescence was observed in the left striatum, indicating successful viral transfection exclusively on the right side of the striatum.
Effects of aerobic training and optogenetic stimulation on motor function in each mouse group
Figure 4A illustrates the results of the cylinder test, indicating a significant increase in the use of the left forelimb by mice in the PE group after 4 weeks of aerobic training (36.17 ± 2.67 vs 41.58 ± 1.47, P < 0.05, F = 18.869). Prior to aerobic exercise, the utilization frequency of the left limb in the PD mouse cohort was markedly reduced relative to the control group. (Fig. 4B, 50.67 ± 3.68 vs 35.82 ± 2.04, P < 0.001, F = 54.569). When compared with the PD group, the PE group exhibited a significant increase in the use of the left forelimb after the third week of aerobic training (Fig. 4C, 33.68 ± 3.41 vs 40.86 ± 1.85, P < 0.01, F = 20.488). In the pole-climbing test (Fig. 4D), the time taken by mice in the PE group to climb the pole decreased significantly from the pre-test baseline after 4 weeks of aerobic training (9.91 ± 0.77 vs 8.51 ± 0.21, P < 0.01, F = 18.084). Additionally, before the onset of aerobic exercise, the climbing duration for the PD mouse cohort was significantly prolonged in comparison to the control group (Fig. 4E, 5.06 ± 0.66 vs 10.15 ± 0.66, P < 0.001, F = 150.105). Moreover, when compared with the PD group, the PE group demonstrated a significant decrease in the time required to climb the pole after 3 weeks of aerobic training (Fig. 4F, 10.14 ± 0.17vs 9.01 ± 0.20, P < 0.01, F = 110.845).
As shown in Fig. 5B, in the cylinder test, there was no significant change in the rate at which the left forelimb was used before and after optogenetic stimulation in any group (P > 0.05). As shown in Fig. 5C, climbing time in the pole test was significantly higher in the C, CE, and PE groups after optogenetic stimulation than before stimulation (51.12 ± 3.35 vs 49.21 ± 4.02; 49.74 ± 2.23 vs 49.20 ± 4.69; 39.16 ± 2.48 vs 40.95 ± 4.47, P < 0.05, F = 34.407, 76.813, 25.423), while there was no significant change in the pole-climbing time in PD mice before and after photostimulation (P > 0.05). The pole-climbing time was significantly higher in the PD group than in the control group after photostimulation (11.37 ± 1.08 vs 7.40 ± 0.77, P < 0.05, F = 53.580).
In vivo electrophysiological results
Dorsal striatal neuron fractionation
Based on neuronal classification waveform and frequency criteria (Fig. 6), 35 MSNs exhibiting distinct distributions across the three main components with well-defined baseline firing frequencies were identified25. The MSNs were distinguished based on extracted waveform features such as spike waveform valley interval, peak interval, and waveform symmetry index.
Figure 7B demonstrates the discrimination of striatal D1-MSNs and D2-MSNs using light activation. Among the 32 neurons responsive to blue light activation at 473 nm, 12 neurons were identified as putative D1-MSNs, accounting for 34.3%, while 20 neurons were identified as putative D2-MSNs, accounting for 57.1%.
Effects of aerobic training on different MSNs in PD mice
Electrode implantation sites were all dorsal striatum (Fig. 7A). According to the method of Soares-Cunha et al., neuronal activation was determined by the degree of response of different neurons to optogenetic stimulation, and neurons were defined as activated by optogenetic stimulation and inhibited by optogenetic stimulation when the 473 nm blue light stimulation was able to make the neurons respond within 5 ms, and when the frequency of the post-stimulation discharges was higher than the baseline value by 20% (D2-MSNs), while it was lower than the baseline value by 20% (Figs. 7B, 8).The baseline discharge frequency of MSNs recorded by the experiment is shown in Fig. 7C. Figure 7D shows the firing frequency of D1-MSNs and D2-MSNs in the dorsal striatum in each mouse group. The overall firing frequency of MSNs was significantly higher in PD mice than in control group mice (1.63 ± 0.44 vs 4.55 ± 3.13, P < 0.01, F = 6.869). In contrast, the firing frequency of MSNs in was significantly lower in PE mice than in PD mice (4.55 ± 3.13 vs 3.47 ± 1.41, P < 0.05, F = 0.871). Figure 7E shows that there were no significant differences in the firing frequency of D1-MSNs among the groups (P > 0.05). Figure 7F shows that the firing frequency of D2-MSNs in the dorsal striatum was significantly higher in the PD group than in the control group (1.72 ± 0.52 vs 6.40 ± 2.34, P < 0.001, F = 19.056), whereas it was significantly lower in the PE group than in the PD group (6.40 ± 2.34 vs 4.28 ± 1.28, P < 0.05, F = 4.323).
Figure 8 illustrates changes in the firing frequency of D1-MSNs and D2-MSNs in the dorsal striatum in each mouse group before, during, and after photostimulation at 473 nm. The firing frequency of D2-MSNs increased after light stimulation and decreased at the end of stimulation. Conversely, the firing frequency of D1-MSNs decreased following stimulation. For a more detailed examination of the statistical outcomes, please refer to the supplementary material provided.
Effect of aerobic training on LFP in PD mice
As shown in Fig. 9, the power spectral density of LFP in the β-band (12–30 Hz) was significantly higher in the dorsal striatal neurons of PD mice than in those of control group mice (− 51.53 ± 1.35 vs − 44.84 ± 0.70, P < 0.001, F = 77.500), while it was significantly lower in the PE group than in the PD group (− 44.84 ± 0.70 vs − 47.39 ± 1.25, P < 0.05, F = 12.614).
Effect of aerobic training on striatal D1R and D2R in PD mice
As shown in Fig. 10, levels of D1R and D2R protein expression in the striatum of were significantly higher in the control group than in the PD group (1.02 ± 0.04 vs 0.47 ± 0.08, P < 0.05, F = 13.498; 1.02 ± 0.04 vs 0.53 ± 0.15, P < 0.001, F = 40.017). Further, D2R protein expression in the striatum was significantly higher in the PE group than in the PD group (0.53 ± 0.15 vs 0.78 ± 0.8, P < 0.05, F = 5.136). Notably, there was no significant difference in striatal D1R expression between PE and PD mice (0.47 ± 0.08 vs 0.45 ± 0.17, P > 0.05).
The positive cell number of D2R in each brain region was quantitatively analyzed. Figure 11 shows that there were no significant differences in the number of D2R positive cells in the ventral striatum among the groups (P > 0.05). However, in the dorsal striatum, a significant decrease in the positive cell number of D2R was observed in the PD group when compared with levels observed in the control group (419.50 ± 9.68 vs 236.00 ± 36.75, P < 0.001, F = 93.253), while a similar, significant increase was observed in PE mice when compared with levels observed in the PD group (284.75 ± 18.69 vs 236.00 ± 36.75, P < 0.05, F = 5.591) (Fig. 12).
Discussion
Epidemiological studies have revealed that engaging in moderate to high-intensity exercise can effectively reduce the risk of developing PD26. Accumulating evidence suggests that aerobic exercise not only improves balance, coordination, and aerobic capacity in patients with PD but also attenuates motor symptoms27. When compared with resistance and flexibility training, aerobic training has been shown to more effectively enhance functional connectivity between specific areas of the striatum and cortex in patients with PD28, thereby improving motor and cognitive function29–31. However, the precise roles of and regulatory mechanisms employed by different MSN subtypes in such behavioral improvements remain to be fully elucidated.
Although the degeneration of DA neurons was identified as a key pathological feature of PD in the early 1960s, no specific treatments currently exist to reverse or protect DA neurons. This remains the case despite substantial efforts and resources invested over the past seven decades. However, evidence suggests that Parkinson's disease encompasses a pre-symptomatic phase lasting 10–20 years or longer, typically characterized by the absence of motor symptoms or the presence of only mild symptoms32. This scenario presents an opportunity to modify or decelerate the pathological progression from presymptomatic to overt PD. Previous studies have demonstrated that encouraging a biased PD model animal to use its affected limb effectively improves motor deficits in that limb and enhances voluntary activity levels18. Such an approach also delays the depletion of striatal tissue DA. However, certain studies indicate that voluntary or forced aerobic exercise only ameliorates motor dysfunction, without mitigating the loss of nigrostriatal DA neurons or enhancing striatal tissue DA levels33. This variation could be attributed to the extent of impairment in the PD model relative to the initiation timing of the exercise intervention. For example, in a chronic MPTP-induced mouse model of PD, a 4-week lower-intensity running-stage exercise intervention begun in the third week of modeling failed to alleviate the loss of DA neurons.
In the current study, we observed a significant increase in the time taken by PD mice to climb the pole and a substantial decrease in the utilization of the left forelimb, indicating clear motor dysfunction in these animals. Studies have indicated that more than 50% of DA neurons in the substantia nigra have already degenerated prior to the onset of motor dysfunction in both patients with PD and animal models34. Simultaneously, DA levels in the striatum decline in parallel with the loss of DA neurons in the substantia nigra35, which affects the regulation of movement by the basal ganglia. Consistent with previous findings, TH levels in substantia nigra/striatum and striatal D2R expression were significantly reduced in our PD mice. After 4 weeks of aerobic training, PD mice exhibited significant decreases in climbing time and significant improvements in left forelimb use, suggesting that the aerobic training program was effective in improving motor function in PD mice. Similar outcomes have been reported in other studies35–37. Additionally, our study demonstrated that specific activation of striatal D2-MSNs with 473-nm light substantially prolongs the time taken by normal mice to climb the pole and reduces utilization of the left forelimb, highlighting a close relationship between the functional activity of D2-MSNs and motor dysfunction in PD mice. As important components of the indirect pathway within the basal ganglia, striatal D2-MSNs are involved in the initiation, selection, and termination of movement38. Optogenetic inhibition of bilateral striatal D2-MSNs disrupts normal movement termination and selection, whereas inhibition of D1-MSNs impairs regular motor behavior24. Consequently, improvements in motor dysfunction through aerobic training may be associated with alterations in the functional activity of D2-MSNs.
Previous studies have revealed that the specific spatial organization of dopaminergic and glutamatergic synapses enables DA to influence MSN activity by modulating glutamatergic synaptic transmission39,40. The synaptic plasticity of dorsal striatal MSNs, regulated by DA, is closely associated with motor skill learning and motor symptoms in PD41. Maintenance of the resting potential in striatal MSNs relies on inward Kir2 K+ channels, which modulate the membrane potential by balancing ion flux toward the K+ equilibrium potential7. Following receptor binding, DA can alter ion channel permeability, thereby influencing neuronal activity. Activation of D2R reduces inward depolarizing currents mediated by Nav1 Na + channels and Cav1.l type Ca2+ channels while increasing the outward hyperpolarizing K+ channel current, thereby facilitating prolonged resting states in D2-MSNs. Conversely, activation of D1R via the PKA pathway promotes Cav1 l-type Ca2+ channel currents, reduces K+ channel currents, and triggers excitation in D1-MSNs42. D1R and D2R colocalize with Glutamate receptors in dendritic spines, representing crucial factors in MSN excitability. Activation of D2R reduces Glutamate release from presynaptic terminals and triggers the dephosphorylation of GluR1 subunits, consequently decreasing the AMPAR current on the surface of MSNs. The PKA pathway mediated by D1R upregulates AMPAR and NMDAR expression on the membrane surface, thereby regulating ion channel dynamics in the neuronal membrane and affecting neuronal functional activity43. Furthermore, D1R activation leads to a reduction in NMDA receptor currents and excitotoxicity, while NMDA enhances D1R signaling. Activation of D1 receptors facilitates the upregulation of NMDA-dependent long-term potentiation (LTP). This interaction inhibits the coupling of CaMK-II with NR2B subunits, leading to decreased phosphorylation of NR2B and a reduction in NMDA receptor currents44–46.
The functions of postsynaptic neurons are often influenced by the binding of neurotransmitters to their receptor proteins. G protein coupled receptors (GPCRs) play a crucial role in the regulation of inter-neuronal communication by modulating intracellular chemical signals47. In the striatum, MSNs express various functional proteins, including D1R, D2R, adenosine A2A receptors, and glutamate receptors, which are essential for maintaining normal postsynaptic function. D1R and D2R, both GPCRs, are primarily located on the dendrites of GABAergic MSNs and receive input from dopaminergic neurons in the SNpc and ventral tegmental area, facilitating internuclear communication48. Consequently, this leads to decreased inhibition of the thalamus by the basal ganglia and promotes motor behavior. Under normal levels of dopaminergic neurons in the striatum, DA can simultaneously activate both D1R and D2R receptors. Specifically, DA binds to D1R to activate D1-MSNs, while binding to D2R inhibits the activity of D2-MSNs. In the absence of DA in the striatum, D2-MSNs lose their inhibition via D2R, leading to sustained excitation under the influence of Glutamate49. In addition, manipulation of striatal D2-MSNs or D2R, either by pharmacological means or optogenetically, affects normal locomotor behaviour in animals50,51. Our results similarly show that the presence of motor dysfunction is accompanied by an increased frequency of striatal D2-MSNs issuance and a decrease in D2R expression.
Our results indicated a significant decrease in the expression of D1R and D2R proteins in the striatum, suggesting a close relationship between PD motor dysfunction and DA receptors. Notably, 4 weeks of aerobic training significantly upregulated D2R expression in the dorsal striatum of PD mice, while D1R levels remained unaffected. Neurotrophic factors, pivotal in mediating neuroplasticity, and improving motor dysfunction in PD through exercise, could contribute to the observed discrepancies. Dating back to 1996, Neeper et al. demonstrated that exercise elevates BDNF mRNA expression across various brain regions in rats52. Similar effects have been observed in subsequent studies on exercise interventions in PD32,53. Conversely, BDNF-deficient mice exhibit a diminished response to exercise interventions54. Furthermore, smilagenin has been shown to safeguard D2R and substantia nigra dopaminergic neurons through BDNF in MPTP-induced mouse models55. Moreover, BDNF-TrkB signaling in striatal D1-MSNs has a protective effect against the development of levodopa-induced dyskinesias (LID), with targeted activation of TrkB agonists reducing LID severity56. Consequently, exercise could mitigate dopaminergic neuron deterioration by activating the BDNF-TrkB signaling pathway, though its protective influence on D1-MSNs may vary from that on D2-MSNs and associated dopaminergic receptors. This suggests that both D1R and D2R in the striatum play a selective role in ameliorating PD-related motor dysfunction through targeted regulation of D2R expression in MSNs in the dorsal striatum. Therefore, 4 weeks of aerobic exercise may improve the excitability of D2-MSNs in PD by selectively modulating D2R expression in the dorsal striatum, restoring the normal function of the indirect pathway in the basal ganglia and alleviating PD-related motor dysfunction.
Nevertheless, our study was subject to some primary limitations. Initially, In consideration of variances between species, further investigations are imperative to substantiate the generalizability of the findings from this study to the human population. Secondly, owing to technical constraints, a direct examination of the link between the reduction of striatal DA and the progression of motor dysfunction was not feasible. Therefore, we suggest that the real-time effects of aerobic exercise on brain DA in PD mice should be further monitored in the future.
Conclusions
Aerobic exercise has shown promising effects in the amelioration of motor dysfunction in patients with PD. Following a 4-week aerobic exercise regimen, we observed a selective reduction in overactivity of D2-MSNs in the dorsal striatum and attenuation of abnormal increases in beta oscillatory electrical activity of LFP in the dorsal striatum. This beneficial outcome was associated with the upregulation of D2R expression, which plays a crucial role in improving motor dysfunction in mice with PD. Optogenetic activation of D2-MSNs partially counteracted the effects of aerobic exercise. Notably, our data support the notion that dorsal striatal D2-MSNs have emerged as pivotal cellular targets for enhancing PD-related motor dysfunction through aerobic exercise.
Supplementary Information
Acknowledgements
This research was funded by the National Natural Science Foundation of China (32071171; 32000833) and Science and Technology Project of Hebei Education Department (QN2020146).
Author contributions
W.C. and J.L. designed the research. M.T., Z.Y., and B.G. performed the behavior experiment. T.Z. and Y.W. performed the electrophysiological experiment. Y.W. and L.W. analyzed the data. Y.L. and K.S. reviewed the manuscript. All authors have read and agreed to the published version of the manuscript.
Data availability
The datasets used and analysed during the current study available from the corresponding author on reasonable request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Yinhao Wang and Longwei Wei.
Contributor Information
Kaixuan Shi, Email: kk1988725@126.com.
Wei Chen, Email: chenwei@hebtu.edu.cn.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-024-63045-4.
References
- 1.Kopecky J. Population age structure and secular stagnation: Evidence from long run data. JEoA. 2023;24:100442. [Google Scholar]
- 2.Tchekalarova J, Tzoneva R. Oxidative stress and aging as risk factors for Alzheimer's disease and Parkinson's disease: The role of the antioxidant melatonin. Int. J. Mol. Sci. 2023;24:3022. doi: 10.3390/ijms24033022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Willis AW. Parkinson disease in the elderly adult. Mo. Med. 2013;110:406–410. [PMC free article] [PubMed] [Google Scholar]
- 4.Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain. 1999;122(Pt 8):1437–1448. doi: 10.1093/brain/122.8.1437. [DOI] [PubMed] [Google Scholar]
- 5.Chen W, Qiao D, Liu X. Progress in the study of striatal neuronal plasticity and the prevention and treatment of movement in Parkinson's disease. Chin. J. Sports Med. 2014;33:729–734. [Google Scholar]
- 6.Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia: A critical reappraisal. Nat. Neurosci. 2014;17:1022–1030. doi: 10.1038/nn.3743. [DOI] [PubMed] [Google Scholar]
- 7.Gerfen CR. Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective. Front. Synaptic Neurosci. 2022;14:1002960. doi: 10.3389/fnsyn.2022.1002960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Haber SN. The place of dopamine in the cortico-basal ganglia circuit. Neuroscience. 2014;282:248–257. doi: 10.1016/j.neuroscience.2014.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tecuapetla F, Matias S, Dugue GP, Mainen ZF, Costa RM. Balanced activity in basal ganglia projection pathways is critical for contraversive movements. Nat. Commun. 2014;5:4315. doi: 10.1038/ncomms5315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Shi K, Liu X, Qiao D. Movement-dependent plasticity of dendritic spines of striatal medium spiny neurons in PD model rats. Sports Sci. 2020;40:54–62. [Google Scholar]
- 11.Malén T, et al. Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort. NeuroImage Clin. 2024;41:103578. doi: 10.1016/j.nicl.2024.103578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Medeiros DDC, et al. A mouse model of sleep disorders in Parkinson's disease showing distinct effects of dopamine D2-like receptor activation. Prog. Neurobiol. 2023;231:102536. doi: 10.1016/j.pneurobio.2023.102536. [DOI] [PubMed] [Google Scholar]
- 13.Parr AC, et al. Genetic variation in the dopamine system is associated with mixed-strategy decision-making in patients with Parkinson's disease. Eur. J. Neurosci. 2023;58:4523–4544. doi: 10.1111/ejn.15875. [DOI] [PubMed] [Google Scholar]
- 14.Zhou X, et al. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia. Neuroimage. 2017;157:209–218. doi: 10.1016/j.neuroimage.2017.05.066. [DOI] [PubMed] [Google Scholar]
- 15.Toy WA, et al. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiol. Dis. 2014;63:201–209. doi: 10.1016/j.nbd.2013.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chen P, Liu X, Ma J, Qiao D. Movement-dependent plasticity of dendritic spines of striatal medium spiny neurons in PD model rats. Sports Sci. 2020;40:54–62. [Google Scholar]
- 17.Zhao G, Zhang D, Qiao D, Liu X. Exercise improves behavioral dysfunction and inhibits the spontaneous excitatory postsynaptic current of D2-medium spiny neurons. Front. Aging Neurosci. 2022;14:1001256. doi: 10.3389/fnagi.2022.1001256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang X, et al. Aerobic exercise improves motor function and striatal MSNs-Erk/MAPK signaling in mice with 6-OHDA-induced Parkinson's disease. Exp. Brain Res. 2022;240:1713–1725. doi: 10.1007/s00221-022-06360-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Høydal MA, Wisløff U, Kemi OJ, Ellingsen O. Running speed and maximal oxygen uptake in rats and mice: Practical implications for exercise training. Eur. J. Cardiovasc. Prev. Rehabil. 2007;14:753–760. doi: 10.1097/HJR.0b013e3281eacef1. [DOI] [PubMed] [Google Scholar]
- 20.Zhang Q-S, et al. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Acta Pharmacol. Sin. 2017;38:1317–1328. doi: 10.1038/aps.2017.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Chen W, Qiao D, Liu X, Shi K. Treadmill exercise improves motor dysfunction and hyperactivity of the corticostriatal glutamatergic pathway in rats with 6-OHDA-induced Parkinson's disease. Neural Plast. 2017;2017:2583910. doi: 10.1155/2017/2583910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yoon, H. H. et al. Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease. Neurosurgery.74 (2014). [DOI] [PubMed]
- 23.Yoon HH, et al. Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease. Neurosurgery. 2014;74:533–540. doi: 10.1227/NEU.0000000000000297. [DOI] [PubMed] [Google Scholar]
- 24.Cruz BF, et al. Action suppression reveals opponent parallel control via striatal circuits. Nature. 2022;607:521–526. doi: 10.1038/s41586-022-04894-9. [DOI] [PubMed] [Google Scholar]
- 25.Wei L, et al. Aerobic exercise improves food reward in obesity-prone rats: mediated by CP-AMPARs of nucleus accumbens. Sports Sci. 2022;42:48–61. [Google Scholar]
- 26.Xu Q, et al. Physical activities and future risk of Parkinson disease. Neurology. 2010;75:341–348. doi: 10.1212/WNL.0b013e3181ea1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Feng YS, et al. The benefits and mechanisms of exercise training for Parkinson's disease. Life Sci. 2020;245:117345. doi: 10.1016/j.lfs.2020.117345. [DOI] [PubMed] [Google Scholar]
- 28.Johansson ME, et al. Aerobic exercise alters brain function and structure in Parkinson's disease: A randomized controlled trial. Ann. Neurol. 2022;91:203–216. doi: 10.1002/ana.26291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fisher BE, et al. Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease. Neuroreport. 2013;24:509–514. doi: 10.1097/WNR.0b013e328361dc13. [DOI] [PubMed] [Google Scholar]
- 30.Hsueh, S.-C. et al. Voluntary physical exercise improves subsequent motor and cognitive impairments in a rat model of Parkinson's disease. Int. J. Mol. Sci.19 (2018). [DOI] [PMC free article] [PubMed]
- 31.Vučković MG, et al. Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride. Mov. Disord. 2010;25:2777–2784. doi: 10.1002/mds.23407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tang C, et al. Treadmill exercise alleviates cognition disorder by activating the FNDC5: Dual role of integrin αV/β5 in Parkinson's disease. Int. J. Mol. Sci. 2023;24:7830. doi: 10.3390/ijms24097830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chen CCW, Erlich AT, Hood DA. Role of Parkin and endurance training on mitochondrial turnover in skeletal muscle. Skelet. Muscle. 2018;8:10. doi: 10.1186/s13395-018-0157-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Brotchie J, Fitzer-Attas C. Mechanisms compensating for dopamine loss in early Parkinson disease. Neurology. 2009;72:S32–S38. doi: 10.1212/WNL.0b013e318198e0e9. [DOI] [PubMed] [Google Scholar]
- 35.Sackner-Bernstein J. Estimates of intracellular dopamine in Parkinson's disease: A systematic review and meta-analysis. J. Parkinsons Dis. 2021;11:1011–1018. doi: 10.3233/JPD-212715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chen W, Wei X, Liu X, Yan K. Effect of exercise on cortex -striatum glutamatergic neurotransmission in PD model rats. J. Beijing Sport Univ. 2015;38:61–66. [Google Scholar]
- 37.van der Kolk, N. M. et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: A double-blind, randomised controlled trial. Lancet. Neurol.18 (2019). [DOI] [PubMed]
- 38.Tai L-H, Lee AM, Benavidez N, Bonci A, Wilbrecht L. Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat. Neurosci. 2012;15:1281–1289. doi: 10.1038/nn.3188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chen W, Shi K, Liu X. Exercise intervention improves behavioral function in PD Rats through modulation of striatal MSNs structural plasticity. Chin. J. Sports Med. 2015;34:228–234. [Google Scholar]
- 40.Augustin SM, Loewinger GC, O'Neal TJ, Kravitz AV, Lovinger DM. Dopamine D2 receptor signaling on iMSNs is required for initiation and vigor of learned actions. Neuropsychopharmacol. 2020;45:2087–2097. doi: 10.1038/s41386-020-00799-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Do J, Kim J-I, Bakes J, Lee K, Kaang B-K. Functional roles of neurotransmitters and neuromodulators in the dorsal striatum. Learn Mem. 2012;20:21–28. doi: 10.1101/lm.025015.111. [DOI] [PubMed] [Google Scholar]
- 42.Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 2011;34:441–466. doi: 10.1146/annurev-neuro-061010-113641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Suarez LM, Solis O, Sanz-Magro A, Alberquilla S, Moratalla R. Dopamine D1 receptors regulate spines in striatal direct-pathway and indirect-pathway neurons. Mov. Disord. 2020;35:1810–1821. doi: 10.1002/mds.28174. [DOI] [PubMed] [Google Scholar]
- 44.Bénac N, et al. Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis. Nat. Commun. 2024;15:27. doi: 10.1038/s41467-023-44301-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Fuxe K, Guidolin D, Agnati LF, Borroto-Escuela DO. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease. Expert Opin. Ther. Targets. 2015;19:377–398. doi: 10.1517/14728222.2014.981529. [DOI] [PubMed] [Google Scholar]
- 46.Lee FJS, et al. Dual regulation of NMDA receptor functions by direct protein–protein interactions with the dopamine D1 receptor. Cell. 2002;111:219–230. doi: 10.1016/S0092-8674(02)00962-5. [DOI] [PubMed] [Google Scholar]
- 47.Lovinger DM. Communication networks in the brain: Neurons, receptors, neurotransmitters, and alcohol. Alcohol Res. Health. 2008;31:196–214. [PMC free article] [PubMed] [Google Scholar]
- 48.Hurley MJ, Jenner P. What has been learnt from study of dopamine receptors in Parkinson's disease? Pharmacol. Ther. 2006;111:715–728. doi: 10.1016/j.pharmthera.2005.12.001. [DOI] [PubMed] [Google Scholar]
- 49.Zhang X, et al. Balance between dopamine and adenosine signals regulates the PKA/Rap1 pathway in striatal medium spiny neurons. Neurochem. Int. 2019;122:8–18. doi: 10.1016/j.neuint.2018.10.008. [DOI] [PubMed] [Google Scholar]
- 50.Parker JG, et al. Diametric neural ensemble dynamics in parkinsonian and dyskinetic states. Nature. 2018;557:177–182. doi: 10.1038/s41586-018-0090-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Qian D, et al. A striatal SOM-driven ChAT-iMSN loop generates beta oscillations and produces motor deficits. Cell Rep. 2022;40:111111. doi: 10.1016/j.celrep.2022.111111. [DOI] [PubMed] [Google Scholar]
- 52.Neeper SA, Gómez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 1996;726:49–56. doi: 10.1016/0006-8993(96)00273-9. [DOI] [PubMed] [Google Scholar]
- 53.Schenkman M, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: A phase 2 randomized clinical trial. JAMA Neurol. 2018;75:219–226. doi: 10.1001/jamaneurol.2017.3517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Bastioli G, et al. Voluntary exercise boosts striatal dopamine release: Evidence for the necessary and sufficient role of BDNF. J. Neurosci. 2022;42:4725–4736. doi: 10.1523/JNEUROSCI.2273-21.2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.He X, et al. Smilagenin protects dopaminergic neurons in chronic MPTP/probenecid-lesioned Parkinson's disease models. Front. Cell Neurosci. 2019;13:18. doi: 10.3389/fncel.2019.00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Pelosi A, Nakamura Y, Girault J-A, Hervé D. BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia. Neurobiol. Dis. 2023;185:106238. doi: 10.1016/j.nbd.2023.106238. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets used and analysed during the current study available from the corresponding author on reasonable request.